NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.45M | -6.64M | -6.83M | -3.61M | -5.34M |
| Total Depreciation and Amortization | 236.80K | 256.40K | 262.00K | 261.60K | 261.40K |
| Total Amortization of Deferred Charges | -192.60K | -192.60K | -324.70K | 0.00 | 192.60K |
| Total Other Non-Cash Items | 1.42M | 1.48M | 1.12M | 935.60K | 962.10K |
| Change in Net Operating Assets | -1.07M | -2.34M | -393.60K | -429.20K | -58.00K |
| Cash from Operations | -7.05M | -7.43M | -6.16M | -2.84M | -3.98M |
| Capital Expenditure | -109.60K | -133.40K | -98.10K | -81.70K | -108.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -109.60K | -133.40K | -98.10K | -81.70K | -108.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.20M | 10.04M | 9.79M | 9.61M | 10.45M |
| Repurchase of Common Stock | -70.40K | -70.70K | -117.00K | -124.70K | -131.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.00K | -923.20K | -984.90K | -1.46M | 187.10K |
| Cash from Financing | 1.17M | 9.05M | 8.69M | 8.03M | 10.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.99M | 1.48M | 2.43M | 5.11M | 6.42M |